Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers
International Journal of Molecular Sciences · 09.08.2024 · 25 (16) · 8703
DOI: 10.3390/ijms25168703 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.08.2024. Verfasst von Jun Chung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Circulating Tumor DNA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peter T. Rowley Breast Cancer Research Projects (Round 7), Carol M. Baldwin Foundation for Breast Cancer Research.
Abstract (Originalsprache)
Liquid biopsy has emerged as a promising noninvasive approach for colorectal cancer (CRC) management. This review focuses on technologies detecting circulating nucleic acids, specifically circulating tumor DNA (ctDNA) and circulating RNA (cfRNA), as CRC biomarkers. Recent advancements in molecular technologies have enabled sensitive and specific detection of tumor-derived genetic material in bodily fluids. These include quantitative real-time PCR, digital PCR, next-generation sequencing (NGS), and emerging nanotechnology-based methods. For ctDNA analysis, techniques such as BEAMing and droplet digital PCR offer high sensitivity in detecting rare mutant alleles, while NGS approaches provide comprehensive genomic profiling. cfRNA detection primarily utilizes qRT-PCR arrays, microarray platforms, and RNA sequencing for profiling circulating microRNAs and discovering novel RNA biomarkers. These technologies show potential in early CRC detection, treatment response monitoring, minimal residual disease assessment, and tumor evolution tracking. However, challenges remain in standardizing procedures, optimizing detection limits, and establishing clinical utility across disease stages. This review summarizes current circulating nucleic acid detection technologies, their CRC applications, and discusses future directions for clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
ORCID-Profile: Young Hwa Soung
Förderung
- Peter T. Rowley Breast Cancer Research Projects (Round 7)
- Carol M. Baldwin Foundation for Breast Cancer Research
Zitieren
APA
Chung, J., Xiao, S., Gao, Y., & Soung, Y. H. (2024). Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers. International Journal of Molecular Sciences, 25(16), 8703. https://doi.org/10.3390/ijms25168703
Vancouver
Chung J, Xiao S, Gao Y, Soung YH. Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers. International Journal of Molecular Sciences. 2024;25(16):8703. doi:10.3390/ijms25168703
BibTeX
@article{Chung2024,
author = {Chung, Jun and Xiao, Sophie and Gao, Yang and Soung, Young Hwa},
title = {Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {16},
pages = {8703},
doi = {10.3390/ijms25168703}
}
EUVIMED